European UPC IP Litigation

1,592 annotated decisions

1,592
Decisions
1
IP Types
10
Courts
Browse by type: patent 1,592

Page 58 of 67 · 1,592 total

patent partially granted · Jul 23, 2024

Oerlikon Textile GmbH & CO KG v.Himson Engineering Private Limited

Milan (IT) Local Division · App_28655/2024

This procedural order addressed a request for confidentiality regarding sensitive documents submitted during an infringement action. The UPC ruled that certain redacted commercial data was protected as confidential information, granting access only to specific parties of the respondent's team. Conversely, a settlement agreement document was excluded from evidence entirely. This decision highlights the court's nuanced approach to balancing trade secret protection with procedural fairness in complex patent litigation.

patent pending · Jul 23, 2024

Oerlikon Textile GmbH & CO KG v.Himson Engineering Private Limited

Milan (IT) Local Division · ORD_40568/2024

In this procedural order within an infringement action, Oerlikon Textile sought protection for confidential information contained in documents submitted during litigation. The UPC Court addressed two key documents: a settlement agreement (Doc n. 37) and commercial data (Doc n. 38). The court ultimately excluded the highly sensitive settlement agreement from evidence while granting Himson Engineering limited, controlled access to the redacted commercial data under strict confidentiality rules.

patent denied · Jul 22, 2024

DISH Technologies L.L.C. v.AYLO PREMIUM LTD

Mannheim (DE) Local Division · App_40530/2024

This decision from the Mannheim Local Court addresses a challenge by AYLO PREMIUM LTD against a confidentiality order established under UPC Rules of Procedure (R. 262A VerfO). The dispute centered on whether three individuals named by the claimants should be excluded from accessing confidential information related to the patent infringement case. The court upheld the original order, finding that the respondent did not provide sufficient justification to restrict access, thereby reinforcing the principle of unrestricted access to the core dispute material.

patent pending · Jul 22, 2024

Dolby International AB v.HP Deutschland GmbH, HP Inc., HP International SARL, HP Austria GmbH, HP France SAS, HP Belgium SPRL, HP Inc Danmark ApS, HP Finland Oy, HP Italy S.r.l., Hewlett-Packard Nederland BV, HP PPS Sverige AB, HPCP – Computing and Printing Portugal, Unipessoal, Lda., Hewlett-Packard d.o.o., Hewlett-Packard Luxembourg SCA, HP Inc Bulgaria EOOD

Düsseldorf (DE) Local Division · App_25069/2024

This UPC decision addresses a procedural matter concerning the protection of confidential information (Rule 262A) within an infringement case involving Dolby International AB and various HP entities. The core issue was defining the scope of access for Access Advance LLC, which had joined as a third-party intervenor in the patent pool dispute. The court granted the status of intervenor but imposed strict limitations on who could view the unredacted confidential documents.

patent denied · Jul 19, 2024

Meril Italy Srl v.Edwards Lifesciences Corporation

Paris (FR) Central Division - Seat · ORD_598366/2023

In a significant UPC decision, the Central Division rejected revocation actions against Edwards Lifesciences Corporation concerning its prosthetic heart valve patent (EP '825). The claimants argued for invalidity based on lack of novelty and inventive step. However, the Court maintained the patent's validity after accepting an amendment submitted by the defendant, underscoring the importance of procedural compliance in UPC litigation.

patent denied · Jul 19, 2024

Meril Italy Srl v.Edwards Lifesciences Corporation

Paris (FR) Central Division - Seat · ORD_598365/2023

In a complex revocation action, the UPC Central Division rejected Meril Italy Srl's attempt to invalidate EP 3 646 825. The patent relates to an advanced prosthetic heart valve with a unique hexagonal cell frame design. Despite multiple procedural maneuvers and consolidation of related counterclaims, the Court upheld the patent's validity after incorporating amendments. This case underscores the UPC's jurisdiction over complex medical device patents and its strict approach to maintaining patent rights unless clear invalidity grounds are established.

patent denied · Jul 19, 2024

Meril Italy Srl v.Edwards Lifesciences Corporation

Paris (FR) Central Division - Seat · ORD_598367/2023

In a significant decision concerning medical device patents, the UPC Central Division rejected revocation actions against EP '825. The patent relates to an advanced prosthetic heart valve with a unique hexagonal cell frame structure designed to prevent leakage. Although Meril Italy Srl initiated the action based on novelty and inventive step arguments, the Court ultimately maintained the patent's validity after considering amendments submitted by Edwards Lifesciences Corporation. This case highlights how procedural conduct, specifically the submission of limitations during proceedings, can determine the outcome of a revocation suit.

patent denied · Jul 19, 2024

Unnamed individual residing in Belgium v.OrthoApnea S.L.

Brussels (BE) Local Division · ORD_42503/2024

This UPC Local Division Brussels order addressed a procedural challenge brought by OrthoApnea S.L. against an earlier interim decision concerning claim amendments and deadlines in an infringement action related to EP 2 331 036. The court rejected the request for partial review, upholding the Judge-Rapporteur's initial ruling that allowed certain procedural adjustments while maintaining strict control over the case timeline. This highlights the UPC's rigorous approach to managing complex litigation and limiting opportunities for extensive procedural delays.

patent granted · Jul 16, 2024

Regeneron Pharmaceuticals Inc. v.Amgen Inc.

Munich (DE) Central Division - Section · ORD_598363/2023

In a significant UPC decision, the Central Division revoked European Patent 3 666 797 B1, which covers PCSK9 inhibitors used for cholesterol reduction. The case involved Regeneron Pharmaceuticals Inc. and Amgen Inc., both major players in the biotech drug market. While the patent was successfully challenged and revoked, the court also ruled on costs, awarding a substantial sum to the successful Claimant (Regeneron). This ruling underscores the high stakes of UPC revocation actions in the competitive pharmaceutical landscape.

patent granted · Jul 16, 2024

Sanofi-Aventis Deutschland GmbH v.Amgen, Inc.

Munich (DE) Central Division - Section · ORD_598362/2023

In a significant decision, the UPC Central Division revoked European Patent EP 3 666 797 B1, which covers PCSK9 inhibitors used in cholesterol-lowering treatments. The case involved Sanofi-Aventis and Amgen, two major players in the biotech drug market. The revocation was based on patentability grounds, specifically concerning inventive step and claim interpretation. This ruling underscores the rigorous standards applied by the UPC when assessing complex biotechnological inventions.

patent denied · Jul 12, 2024

Seoul Viosys Co., Ltd. v.expert e-Commerce GmbH and expert klein GmbH

Düsseldorf (DE) Local Division · App_40855/2024

This Düsseldorf Local Court decision addressed a request from Seoul Viosys Co., Ltd. for court-provided simultaneous interpretation during oral proceedings, despite having English proficiency. The court rejected the request, emphasizing that since English was an available procedural language and the claimant deliberately chose German, they must bear the costs of their own interpreter. This ruling reinforces the principle that parties must utilize available procedural options when seeking to participate in hearings.

patent dismissed · Jul 11, 2024

KraussMaffei Extrusion GmbH v.TROESTER GmbH & Co. KG

Munich (DE) Local Division · ORD_598303/2023

In a case concerning patent infringement related to extrusion technology, KraussMaffei Extrusion GmbH successfully withdrew its lawsuit against TROESTER GmbH & Co. KG after reaching an out-of-court settlement. The UPC Local Division accepted the withdrawal and terminated the proceedings. Crucially, the court ruled that because the litigation was not yet fully concluded—due to pending issues like expert reports and parallel EPO appeal decisions—the claimant was entitled to a partial refund of their court fees.

patent denied · Jul 11, 2024

Apple Retail Deutschland B.V. & Co. KG et al. v.Ona Patents SL

Luxembourg (LU) · App_39101/2024

This UPC Board of Appeal decision addressed a procedural motion filed by Apple seeking to accelerate the appeal process and reduce the deadline for Ona's reply. The court ultimately denied the request, holding that while acceleration was possible, Apple failed to demonstrate sufficient grounds to override Ona's right to a fair trial. This case underscores the judiciary's careful balancing act between party efficiency demands and fundamental procedural fairness within the UPC framework.

patent dismissed · Jul 11, 2024

KraussMaffei Extrusion GmbH v.TROESTER GmbH & Co. KG

Munich (DE) Local Division · App_40022/2024

In this UPC case concerning patent infringement, the claimant (KraussMaffei Extrusion GmbH) successfully withdrew its action against the respondent (TROESTER GmbH & Co. KG). The court accepted the withdrawal because both parties had reached an out-of-court settlement and the respondent consented to the claim's termination. Crucially, the court ruled that since the oral proceedings were not yet finalized—due to pending issues like expert reports or EPO appeal outcomes—the claimant was entitled to a partial refund of 20% of the court fees.

patent partially granted · Jul 10, 2024

Panasonic Holdings Corporation v.Xiaomi Technology Germany GmbH, Xiaomi Technology France S.A.S, Xiaomi Technology Italy S.R.L, Xiaomi Technology Netherlands B.V., Odiporo GmbH, Shamrock Mobile GmbH

Mannheim (DE) Local Division · App_32822/2024

This decision from the Lokalkammer Mannheim addresses a request for protective measures concerning confidential information, specifically patent licensing agreements between Panasonic and Xiaomi entities. The court partially granted the protection regime, establishing strict rules on who can access these sensitive documents. This ruling highlights the UPC's detailed procedural mechanisms for managing trade secrets during litigation.

patent denied · Jul 10, 2024

Panasonic Holdings Corporation v.Guangdong OPPO Mobile Telecommunications Corp. Ltd.

Munich (DE) Local Division · App_39247/2024

In this UPC decision, the court addressed a procedural dispute regarding the submission of pleadings in an infringement case. The respondents sought extensions for their reply and rejoinder, citing redacted documents from the claimant's initial filing. However, the court rejected these requests, establishing a strict rule that placeholders via redactions are procedurally unacceptable. This ruling emphasizes the importance of full transparency and timely disclosure of all arguments to ensure a fair defense process in UPC litigation.

patent referred · Jul 10, 2024

MED-EL Elektromedizinische Geräte Gesellschaft m.b.H. v.Advanced Bionics AG, Advanced Bionics GmbH, Advanced Bionics Sarl

Mannheim (DE) Local Division · ORD_35569/2024

In this UPC case concerning infringement of EP4074373, the Local Division decided to refer the revocation counterclaim and the claimant's request for patent amendment to the Central Division in Paris. This decision was based on procedural efficiency, as the core arguments against the patent were already being litigated in a prior central action initiated by one of the defendants. The court ruled that maintaining parallel proceedings would violate the principle of process economy.

patent partially granted · Jul 10, 2024

Panasonic Holdings Corporation v.Xiaomi Technology Germany GmbH, Xiaomi Technology France S.A.S, Xiaomi Technology Italy S.R.L, Xiaomi Technology Netherlands B.V., Odiporo GmbH, Shamrock Mobile GmbH

Mannheim (DE) Local Division · App_32822/2024

In a procedural ruling, the UPC Local Division of Mannheim addressed Panasonic Holdings Corporation's request for confidentiality protection concerning sensitive information related to its patent licensing agreements with third parties. The court partially granted this request, establishing strict rules governing who can access and how the confidential documents may be used within the proceedings. This decision underscores the UPC's commitment to protecting commercially sensitive data during litigation, balancing transparency requirements with proprietary interests.

patent partially granted · Jul 9, 2024

Panasonic Holdings Corporation v.OROPE Germany GmbH; Guangdong OPPO Mobile Telecommunications Corp. Ltd.

Mannheim (DE) Local Division · App_32695/2024

This decision from the Mannheim Local Court addresses a request for trade secret protection (R. 262A VerfO) in connection with patent litigation involving Panasonic and OPPO/OROPE. The core dispute centered on the scope of confidentiality, specifically regarding licensing agreements and negotiations. While the court upheld some level of protection for sensitive information, it simultaneously limited access rights requested by the defendants to ensure procedural fairness across parallel UPC and national proceedings.

patent pending · Jul 9, 2024

Panasonic Holdings Corporation v.OROPE Germany GmbH

Mannheim (DE) Local Division · App_39331/2024

In this procedural order, the UPC Court in Mannheim extended the deadlines for OROPE Germany GmbH to submit its pleadings regarding the FRAND aspect of the dispute. The extension was granted following a decision on the trade secret regime and aims to allow both parties sufficient time to address the complex licensing terms. This highlights the court's focus on ensuring procedural fairness while managing the complexity inherent in FRAND disputes.

patent partially granted · Jul 9, 2024

Panasonic Holdings Corporation v.OROPE Germany GmbH; Guangdong OPPO Mobile Telecommunications Corp. Ltd.

Mannheim (DE) Local Division · App_32695/2024

This UPC decision addressed a motion for protective measures concerning confidential information related to patent licensing and FRAND negotiations in the case involving Panasonic Holdings Corporation. The court carefully balanced the claimant's need for secrecy regarding sensitive commercial data against the respondents' demands for broader access during litigation. Ultimately, the protection was partially granted, establishing strict rules on who can view the documents and for what purpose.

patent pending · Jul 8, 2024

Individual (unnamed) v.OrthoApnea S.L.

Brussels (BE) Local Division · App_37702/2024

In this procedural order, the UPC Local Division in Brussels addressed an objection raised by OrthoApnea S.L. against the claimant's ability to amend their infringement case. The court rejected the respondents' attempt to block the addition of new facts and arguments based on equivalence. This decision reinforces that while initial pleadings are crucial, the procedural rules allow for necessary adjustments during litigation, provided they maintain coherence with the ongoing proceedings.

patent partially granted · Jul 7, 2024

ARM Limited v.ICPillar LLC

Luxembourg (LU) · App_40131/2024

This UPC Court of Appeal decision addresses a procedural application concerning service and confidentiality during appeal proceedings related to infringement of EP 3000239. Although the court confirmed that ARM was technically served with ICPillar's statement of appeal, it acknowledged technical difficulties preventing ARM from accessing the unredacted version of Exhibit 4 (an insurance policy). Consequently, the Court granted an extension for ARM to file its response, ensuring due process is maintained despite CMS issues.

patent partially granted · Jul 6, 2024

Panasonic Holdings Corporation v.Guangdong OPPO Mobile Telecommunications Corp. Ltd.

Munich (DE) Local Division · App_15611/2024

This UPC decision addressed a request for confidentiality protection under Rule 262A VerfO in an infringement case involving OPPO and Panasonic. The court confirmed that the information was indeed confidential but modified the scope of access and rejected the demand for document destruction post-trial. This ruling provides clarity on balancing the need for secrecy with the practical requirements of litigation, particularly regarding permissible access by legal representatives.

1 •••575859•••67